Awad, M. M., Forde, P. M., Girard, N., Spicer, J., Wang, C., Lu, S., Mitsudomi, T., Felip, E., Broderick, S. R., Swanson, S. J., Brahmer, J., Kerr, K., Saylors, G. B., Chen, K., Gharpure, V., Neely, J., Balli, D., Hu, N., Pulla, M. P. (2025). Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02239